Literature DB >> 25617412

CypRules: a rule-based P450 inhibition prediction server.

Chi-Yu Shao1, Bo-Han Su1, Yi-Shu Tu1, Chieh Lin1, Olivia A Lin1, Yufeng J Tseng2.   

Abstract

UNLABELLED: Cytochrome P450 (CYPs) are the major enzymes involved in drug metabolism and bioactivation. Inhibition models were constructed for five of the most popular enzymes from the CYP superfamily in human liver. The five enzymes chosen for this study, namely CYP1A2, CYP2D6, CYP2C19, CYP2C9 and CYP3A4, account for 90% of the xenobiotic and drug metabolism in human body. CYP enzymes can be inhibited or induced by various drugs or chemical compounds. In this work, a rule-based CYP inhibition prediction online server, CypRules, was created based on predictive models generated by the rule-based C5.0 algorithm. CypRules can predict and provide structural rulesets for CYP inhibition for each compound uploaded to the server. Capable of fast execution performance, it can be used for virtual high-throughput screening (VHTS) of a large set of testing compounds.
AVAILABILITY AND IMPLEMENTATION: CypRules is freely accessible at http://cyprules.cmdm.tw/ and models, descriptor and program files for all compounds are publically available at http://cyprules.cmdm.tw/sources/sources.rar.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25617412     DOI: 10.1093/bioinformatics/btv043

Source DB:  PubMed          Journal:  Bioinformatics        ISSN: 1367-4803            Impact factor:   6.937


  9 in total

1.  The Role of Drug Metabolites in the Inhibition of Cytochrome P450 Enzymes.

Authors:  Momir Mikov; Maja Đanić; Nebojša Pavlović; Bojan Stanimirov; Svetlana Goločorbin-Kon; Karmen Stankov; Hani Al-Salami
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2017-12       Impact factor: 2.441

2.  In Silico Tools and Software to Predict ADMET of New Drug Candidates.

Authors:  Supratik Kar; Kunal Roy; Jerzy Leszczynski
Journal:  Methods Mol Biol       Date:  2022

3.  A combinatorial approach for the discovery of cytochrome P450 2D6 inhibitors from nature.

Authors:  Johannes Hochleitner; Muhammad Akram; Martina Ueberall; Rohan A Davis; Birgit Waltenberger; Hermann Stuppner; Sonja Sturm; Florian Ueberall; Johanna M Gostner; Daniela Schuster
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

Review 4.  Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.

Authors:  Jonathan D Tyzack; Johannes Kirchmair
Journal:  Chem Biol Drug Des       Date:  2019-01-15       Impact factor: 2.817

5.  Molecular Dynamics Simulation Framework to Probe the Binding Hypothesis of CYP3A4 Inhibitors.

Authors:  Yusra Sajid Kiani; Kara E Ranaghan; Ishrat Jabeen; Adrian J Mulholland
Journal:  Int J Mol Sci       Date:  2019-09-10       Impact factor: 5.923

6.  Novel C7-Substituted Coumarins as Selective Monoamine Oxidase Inhibitors: Discovery, Synthesis and Theoretical Simulation.

Authors:  Dong Wang; Ren-Yuan Hong; Mengyao Guo; Yi Liu; Nianhang Chen; Xun Li; De-Xin Kong
Journal:  Molecules       Date:  2019-11-05       Impact factor: 4.411

7.  Ensemble modeling with machine learning and deep learning to provide interpretable generalized rules for classifying CNS drugs with high prediction power.

Authors:  Tzu-Hui Yu; Bo-Han Su; Leo Chander Battalora; Sin Liu; Yufeng Jane Tseng
Journal:  Brief Bioinform       Date:  2022-01-17       Impact factor: 11.622

8.  Machine learning-driven identification of drugs inhibiting cytochrome P450 2C9.

Authors:  Elodie Goldwaser; Catherine Laurent; Nathalie Lagarde; Sylvie Fabrega; Laure Nay; Bruno O Villoutreix; Christian Jelsch; Arnaud B Nicot; Marie-Anne Loriot; Maria A Miteva
Journal:  PLoS Comput Biol       Date:  2022-01-26       Impact factor: 4.475

Review 9.  Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.

Authors:  Tyler C Beck; Kyle R Beck; Jordan Morningstar; Menny M Benjamin; Russell A Norris
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.